行情报告详情

首页 · 行情 · 医药健康与生命科学

▥
胃泌素激素市场(2026—2031)主要参与者
医药健康与生命科学

胃泌素激素市场(2026—2031)

Gastrin Hormone Market

胃泌素激素市场规模预计由2026年的16.2亿美元增至2031年的23.4亿美元,预测期复合年增长率为7.55%。北美是当前最大市场,亚太地区增长最快。

浏览7
更新时间2026-09-02
内容类型市场研究报告

市场研究正文

规模、增长、细分、驱动因素与关键问题

▤
内容模板:完整版

当前质量分 100.00,审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。

核心结论

胃泌素激素市场规模预计由2026年的16.2亿美元增至2031年的23.4亿美元,预测期复合年增长率为7.55%。北美是当前最大市场,亚太地区增长最快。

市场走势

结构化指标

指标年份数值性质
复合年增长率20317.55%机构预测
市场规模2026USD 1.62 billion机构预测
市场规模2031USD 2.34 billion机构预测

细分市场份额

research reagents and cell signaling application · 202544.140%
hospitals end_user · 202546.140%
North America geography · 202535.610%
Gastrin-17 product_type · 202534.310%
ammonium acetate salt_type · 202545.240%

市场结构

维度细分项年份份额
applicationresearch reagents and cell signaling202544.140%
end_userhospitals202546.140%
geographyNorth America202535.610%
product_typeGastrin-17202534.310%
salt_typeammonium acetate202545.240%

关键结论

  • application 维度中,research reagents and cell signaling 在 2025 年的公开份额为 44.14%。
  • end_user 维度中,hospitals 在 2025 年的公开份额为 46.14%。
  • geography 维度中,North America 在 2025 年的公开份额为 35.61%。
  • product_type 维度中,Gastrin-17 在 2025 年的公开份额为 34.31%。
  • salt_type 维度中,ammonium acetate 在 2025 年的公开份额为 45.24%。

主要参与者

  1. Merck KGaA
  2. Bio-Techne Corporation
  3. RayBiotech Life, Inc.
  4. Thermo Fisher Scientific Inc.
  5. Biohit Oyj

增长驱动因素

因素影响 CAGR地区相关性影响周期
Synthetic Gastrin and Pentagastrin Reagent Availability+1.800%Global, with production concentration in North America, Europe, and ChinaShort term (≤ 2 years)
Gastrin-17 Testing for Atrophic Gastritis and H. pylori Disease+1.500%Asia-Pacific core, with expansion into Europe and the Middle East and AfricaMedium term (2-4 years)
Gastric Organoid and Cancer Research Use+1.000%North America and Europe academic research hubs, with growth in Asia-PacificMedium term (2-4 years)
Hypergastrinemia and Zollinger-Ellison Syndrome Referrals+0.700%North America and Europe, with specialist gastroenterology centers globallyMedium term (2-4 years)
Near-Patient Gastric Biomarker Testing+1.200%Asia-Pacific and South America, with early use in India, Chile, and the United KingdomMedium term (2-4 years)
Gastrin-Targeted Oncology and Receptor Research+0.800%North America and Europe for clinical work, Asia-Pacific for preclinical workLong term (≥ 4 years)

市场制约因素

因素影响 CAGR地区相关性影响周期
Preanalytical Variability From Fasting, PPI Use, Kidney Failure, and Biotin-0.800%Global, with the strongest effect in ambulatory and community settings without pretest protocolsMedium term (2-4 years)
Limited Clinical Translation of CCK2 Receptor Antagonists-0.600%North America and Europe clinical pipeline, with global preclinical activityLong term (≥ 4 years)
Low Disease-Specific Gastrin Test Ordering-0.500%Global, with a stronger effect in primary care and lower-income settingsShort term (≤ 2 years)
Cold-Chain, Purity, and Lot-Consistency Requirements-0.400%Global, with added challenges in tropical climates and emerging marketsMedium term (2-4 years)

报告关注的关键问题

What drives the Gastrin hormone market?

The Gastrin hormone market is supported by synthetic peptide supply, Gastrin-17 testing for atrophic gastritis, Helicobacter pylori assessment, and gastric organoid research.

What is the projected growth rate for the Gastrin hormone market?

The Gastrin hormone market is projected to grow at a CAGR of 7.55% from 2026 to 2031, reaching USD 2.34 billion by 2031.

Which Gastrin hormone market product has the largest share?

Gastrin-17 held the largest product type share at 34.31% in 2025 and is projected to grow at a CAGR of 8.25% through 2031.

Which Gastrin hormone market application is growing fastest?

Atrophic gastritis and Helicobacter pylori assessment is projected to grow at a CAGR of 8.42% through 2031.

Which Gastrin hormone market region is expected to grow fastest?

Asia-Pacific is projected to record the highest regional CAGR at 8.25% through 2031.

What limits wider Gastrin hormone market test use?

Proton pump inhibitor use, fasting requirements, biotin interference, and laboratory reagent supply disruptions can affect testing workflows.

市场概览

  • 增长最快市场:亚太地区
  • 最大市场:北美
  • 市场集中度:中等
Vieter 校准:机构预测不等于实际成交、订单、交付或出货。跨报告比较需要同时核对市场边界、基准年、币种及是否包含软件服务。本站不提供报告原文或全文译文。
查看来源:Mordor Intelligence
评论0